Abstract
The synthesis of some novel thiazolocoumarins is described. These polyheterocyclic compounds have been synthesized under microwave irradiation via the corresponding imino-1,2,3-dithiazoles besides cyanoimidoyl chloride derivatives.
Keywords: Coumarin, imino-1,2,3-dithiazoles, thiazole, cyanoimidoyl chloride, isothiocyanate
Letters in Organic Chemistry
Title: Synthesis of Novel Coumarin Derivatives 7,8-Fused onto Thiazole
Volume: 2 Issue: 8
Author(s): Stephane Frere, Valerie Thiery and Thierry Besson
Affiliation:
Keywords: Coumarin, imino-1,2,3-dithiazoles, thiazole, cyanoimidoyl chloride, isothiocyanate
Abstract: The synthesis of some novel thiazolocoumarins is described. These polyheterocyclic compounds have been synthesized under microwave irradiation via the corresponding imino-1,2,3-dithiazoles besides cyanoimidoyl chloride derivatives.
Export Options
About this article
Cite this article as:
Frere Stephane, Thiery Valerie and Besson Thierry, Synthesis of Novel Coumarin Derivatives 7,8-Fused onto Thiazole, Letters in Organic Chemistry 2005; 2 (8) . https://dx.doi.org/10.2174/157017805774717409
DOI https://dx.doi.org/10.2174/157017805774717409 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Molecular Mechanisms and Proposed Targets for Selected Anticancer Gold Compounds
Current Topics in Medicinal Chemistry Progress in the Preclinical Discovery and Clinical Development of Class I and Dual Class I/IV Phosphoinositide 3-Kinase (PI3K) Inhibitors
Current Medicinal Chemistry Reversal of Resistance to Oxazaphosphorines
Current Cancer Drug Targets Recent Progress in the Development of Anticancer Agents
Current Medicinal Chemistry - Anti-Cancer Agents Population Pharmacogenomics and Personalized Medicine Research in Hungary: Achievements and Lessons Learned
Current Pharmacogenomics and Personalized Medicine Neutral Actions of Raltegravir on Adipogenesis, Glucose Metabolism and Lipolysis in 3T3-L1 Adipocytes
Current HIV Research Imatinib Mesylate for the Treatment of Solid Tumours: Recent Trials and Future Directions
Current Enzyme Inhibition Distribution, Bioactivities and Therapeutical Potentials of Pentagalloylglucopyranose
Current Bioactive Compounds Bruton Kinase Inhibitors in Chronic Lymphocytic Leukemia
Anti-Cancer Agents in Medicinal Chemistry Progresses in TCM Metal-Based Antitumour Agents
Anti-Cancer Agents in Medicinal Chemistry Folate Targeted Solid Lipid Nanoparticles of Simvastatin for Enhanced Cytotoxic Effects of Doxorubicin in Chronic Myeloid Leukemia
Current Nanoscience The Role of Mitochondria in Cancer Induction, Progression and Changes in Metabolism
Mini-Reviews in Medicinal Chemistry Application and Interpretation of Genome-Wide Association (GWA) Studies for Informing Pharmacogenomic Research - Examples from the Field of Age-Related Macular Degeneration
Current Molecular Medicine Global Gene Expression in Classification, Pathogenetic Understanding and Identification of Therapeutic Targets in Acute Myeloid Leukemia
Current Pharmaceutical Biotechnology The Role of SHP-2 in Cell Signalling and Human Disease
Current Enzyme Inhibition Biofunctional Peptides from Milk Proteins: Mineral Binding and Cytomodulatory Effects
Current Pharmaceutical Design Transposons for Gene Therapy!
Current Gene Therapy Advances and Challenges in the Synthesis of Highly Oxidised Natural Phenols with Antiviral, Antioxidant and Cytotoxic Activities
Current Medicinal Chemistry Current Advances in Retroviral Gene Therapy
Current Gene Therapy A Novel Multiple Tyrosine-kinase Targeted Agent to Explore the Future Perspectives of Anti-Angiogenic Therapy for the Treatment of Multiple Solid Tumors: Cabozantinib
Anti-Cancer Agents in Medicinal Chemistry